Feb 15,2024

Biofourmis and WellSpan Health Collaborate to Deliver High-Quality Hospital-Level Acute and Post-Discharge Care to Patients at Home

Biofourmis and WellSpan Health are collaborating to enhance hospital-level acute and post-discharge care at home for patients. WellSpan, an advanced health system with eight hospitals, will use Biofourmis’s remote patient management platform to replace its current system. This platform integrates with WellSpan’s Epic EMR system, providing continuous patient monitoring, clinical insights, and automated care prompts. The partnership aims to manage over 400 patients monthly, reduce hospital readmission rates, and expand hospital-at-home patient volumes by 75% in three years.

COLLABORATION PARTNERSHIP

#institution

#rpm

View Analyst & Ambassador Comments
Go to original news
Feb 13,2024

Biofourmis Secures Four New Agreements with Top-20 Pharma on Strength of Platform for Digital Clinical Trials and Digital Biomarkers

Biofourmis has secured four new agreements with top-20 pharmaceutical companies to enhance digital clinical trials and digital biomarker development, particularly in oncology. These partnerships focus on developing digital biomarkers and safety monitoring algorithms for conditions like cytokine release syndrome (CRS). Biofourmis' platform, which supports remote data collection and patient monitoring, aims to reduce study timelines and improve trial efficiency.

PRODUCT

#rpm

View Analyst & Ambassador Comments
Go to original news
May 14,2024

Vida Health Collaborates with OUTRIGGER Resorts & Hotels to Enhance Employee Benefits with Innovative Diabetes Management Program

Vida Health has partnered with OUTRIGGER Resorts & Hotels to enhance OUTRIGGER’s employee benefits with personalized diabetes management solutions. This program, called Chronic Pathway, provides individualized care plans, medical nutrition therapy, medication management, and remote patient monitoring for eligible employees. Vida Health's CEO, Joe Murad, emphasized the program's innovative approach to improving employees' health outcomes.

PRODUCT

#virtual care

#rpm

#coaching

View Analyst & Ambassador Comments
Go to original news
May 09,2024 TOP STORY

Senseonics, Rimidi partner on remote diabetes monitoring program

Senseonics has partnered with Rimidi to develop a remote patient monitoring (RPM) program utilizing Senseonics' Eversense continuous glucose monitor (CGM). The Eversense CGM, known for its long wear time and accuracy, recently received FDA approval for integration with insulin pumps. The RPM program, expected to launch by the third quarter of 2024, aims to optimize diabetes management between office visits. It will integrate Eversense glucose data into Rimidi's clinical management platform, facilitating remote monitoring aligned with Medicare's reimbursable telehealth programs. The collaboration seeks to improve patient engagement, drive workflow optimization, and provide clinical decision support, ultimately enhancing diabetes outcomes and reducing healthcare costs.

COLLABORATION PARTNERSHIP

#connected device

#cgm

#rpm

View Analyst & Ambassador Comments
Go to original news
Apr 25,2024

Lupin Digital Health’s platform receives Class C medical device license from CDSCO

Lupin Digital Health's Lyfe platform has obtained approval as a Class C Medical Device from the Central Drugs Standard Control Organization (CDSCO), marking India’s first clinically proven remote cardiac rehabilitation program. Lyfe aims to enhance heart health and quality of life. Rajeev Sibal, President-India Region Formulations at Lupin, highlights the company's dedication to cardiac care excellence. Sidharth Srinivasan, CEO of Lupin Digital Health, underscores the significance of this license, emphasizing Lyfe's potential to support millions of cardiac patients and improve health outcomes.

REGULATORY

#rpm

View Analyst & Ambassador Comments
Go to original news
Apr 23,2024

Community Health Network Selects Biofourmis to Help Drive Care-at-Home Outcomes Across the Continuum

Biofourmis has been chosen by Community Health Network to enhance and expand its care-at-home services in central Indiana. Community will implement Biofourmis’ technology-enabled solution to remotely monitor and care for patients across various clinical needs, aiming to reduce hospital readmissions and emergency visits. By leveraging telehealth, remote patient monitoring, and AI-driven analytics, Community seeks to offer high-quality care comparable to in-person settings. Biofourmis’ platform will integrate with Community’s existing systems, ensuring seamless care transitions and personalized patient support.

COLLABORATION PARTNERSHIP

#institution

#rpm

#telehealth

View Analyst & Ambassador Comments
Go to original news
Apr 15,2024

DexCom, MD Revolution Unite to Boost Diabetes Management

DexCom and MD Revolution recently announced their partnership, where Dexcom is likely to integrate its industry-leading continuous glucose monitoring (CGM) systems with MD Revolution’s remote care management.  As a result of the partnership, patients' glucose monitoring data can now be made available to clinicians through MD Revolution’s care management platform, which is likely to empower clinicians to make informed decisions and provide better patient care. MD Revolution offers a remote care management platform that seamlessly integrates with an ecosystem of EHRs, data partners, and devices to power comprehensive remote care for large practices, health systems and healthcare organizations. 

COLLABORATION PARTNERSHIP

#connected device

#cgm

#rpm

View Analyst & Ambassador Comments
Go to original news
Mar 28,2024

Elekta partners with MSD to enhance kidney cancer care using digital solutions

Elekta announced a partnership with MSD (Merck & Co., USA) to develop digital patient monitoring for people with advanced renal cell carcinoma (RCC), using Elekta’s Kaiku Health solution, a digital platform for patient engagement and reported outcomes monitoring. Elekta, with support from MSD, will develop a digital module for patients, keeping them connected with their care team, and educating them about their disease, the treatment and possible side effects. This module includes comprehensive symptom monitoring and patient support, providing patients with tailored and timely symptom monitoring. In addition, the module offers digital education and support materials created specifically for immuno-oncology (IO)-based combination therapy in advanced RCC. The module will be validated in 2024 in collaboration with multiple leading cancer clinics in Europe.

COLLABORATION PARTNERSHIP

#r&d

#rpm

View Analyst & Ambassador Comments
Go to original news
Jan 08,2024

NuvoAir and Cary Medical Management announce partnership to bring high-quality cardiopulmonary care to rural North Carolina

NuvoAir Medical and Cary Medical Management (CMM), a pioneer in transforming traditional primary care into high-performing value-based care clinics, announced their partnership to bring high-quality specialty care to patients in North Carolina. NuvoAir Medical will enable the primary care clinics under CMM’s management to provide in-home and virtual care for patients with complex heart and lung issues including Asthma, COPD, and CHF. NuvoAir Medical will see patients with these conditions through its virtual-first clinic that combines ongoing, empathetic care from a team of specialists with remote monitoring technology to ensure no patient is left behind.

COLLABORATION PARTNERSHIP

#institution

#virtual care

#rpm

View Analyst & Ambassador Comments
Go to original news
May 11,2023

NuvoAir and Medidata Partner to Advance Clinical Trials with Pulmonary Digital Biomarkers

NuvoAir is excited to share its new partnership with Medidata, a leading digital transformation company in life sciences and the largest provider of electronic data capture (EDC) working across 30K clinical trials worldwide. This collaboration advances the opportunities for studies to capture respiratory endpoints from both at-home and in-clinic settings, improving the participant and study site experience and allowing trials to scale at speed. The Medidata Sensor Cloud Network will now integrate NuvoAir’s suite of connected devices, which can be used in decentralized and hybrid trials across a range of therapeutic areas requiring respiratory endpoints.

COLLABORATION PARTNERSHIP

#connected device

#mobile app

#rpm

View Analyst & Ambassador Comments
Go to original news
Subscribe to RPM